Clarivate Plc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Matitiahu Shem-Tov
- Full Time Employees
- 12,000
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- 70 St. Mary Axe London GL United Kingdom EC3A 8BE
- IPO Date
- Oct 29, 2018
- CIK
- 0001764046
- Website
- clarivate.com
- Similar Companies
- Business
- Clarivate Plc (NYSE: CLVT) provides trusted insights and analytics to accelerate innovation and improve health worldwide. The company offers subscription-based information services and workflow solutions; these include Web of Science for citation indexing and research discovery, Cortellis for life sciences intelligence and competitive benchmarking, Derwent for patent analytics and IP protection, ProQuest for academic and public library content, and MarkMonitor for brand protection and online trademark management. Clarivate serves academic institutions, governments, life sciences and healthcare companies, and corporations across intellectual property, life sciences, academia, and government sectors; it operates globally with a presence in over 100 countries. Founded in 2016 as a spin-off from Thomson Reuters and headquartered in London, United Kingdom, the company has no major parent but maintains key subsidiaries such as ProQuest and Clarivate Analytics entities. In late 2024, Clarivate completed the acquisition of Leerink Partners to bolster its healthcare investment banking capabilities; it also launched enhanced AI-driven features in Cortellis and Web of Science platforms amid ongoing strategic expansions into predictive analytics for drug development and IP management.
Company News
Clarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
Clarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
What Clarivate (CLVT) Said on Its Q3 Earnings Call
Clarivate Plc (CLVT) Q3 2026 Earnings Call Transcript
Clarivate PLC (CLVT) Beats Q3 Earnings Estimates
Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation
Clarivate to Bring Trusted Trademark Data into Microsoft Copilot Through IPOne
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence
Clarivate PLC (NYSE:CLVT) Stock Has Consensus Price Target of $3.02 According to Analysts
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Clarivate (NYSE:CLVT) Hits New 12-Month Low – What’s Next?
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
Clarivate PLC (NYSE:CLVT) Receives $3.02 Consensus Price Target from Brokerages
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs